Johnson & Johnson reported robust quarterly and annual growth, exceeding expectations with strong sales and earnings. Management's optimistic outlook for 2022, strategic initiatives, and confident handling of macroeconomic challenges enhance investor confidence. These factors are likely to drive a positive short-term impact on the stock price.

[1]